SMTL ID : 8fy1.1

E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2)

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.56 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x YF8: N-[8-(4-{[(1R,3R,4S)-4-(4-chlorophenyl)-1-methyl-3-{[4-(4-{[4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-(trifluoromethanesulfonyl)benzene-1-sulfonyl]carbamoyl}phenyl)piperazin-1-yl]methyl}cyclohexyl]methyl}piperazin-1-yl)-8-oxooctanoyl]-3-methyl-L-valyl-(4R)-4-hydroxy-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Nayak, D. et al., Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL. Nat Commun (2024)
Release Date
2024-04-10
Peptides
von Hippel-Lindau disease tumor suppressor: A
Elongin-B: B
Elongin-C: C
Apoptosis regulator Bcl-2: D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D